An Exploratory Clinical Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Diseases

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT06978647

Title field or adapter rule

{'original_value': 'An Exploratory Clinical Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Diseases', 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:34.083244+00:00

Published At

2026-10-21T00:00:00+00:00

Record Updated At

2026-10-21

Source Retrieved At

2026-10-31T22:18:41.628690+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Systemic Lupus Erythematosus (SLE)", "Systemic Sclerosis (SSc)", "Inflammatory Myopathy", "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis", "Antiphospholipid Syndrome (APS)", "Rheumatoid Arthritis (RA)", "IgG4-Related Diseases", "Sjogren\u0026#39;s Syndrome"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-21", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT06978647"

protocolSection.identificationModule.officialTitle

"An Exploratory Clinical Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Diseases"

protocolSection.statusModule.overallStatus

"RECRUITING"

protocolSection.designModule.phases

["PHASE1"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Systemic Lupus Erythematosus (SLE) (protocolSection.conditionsModule.conditions)
• Systemic Sclerosis (SSc) (protocolSection.conditionsModule.conditions)
• Inflammatory Myopathy (protocolSection.conditionsModule.conditions)
• Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (protocolSection.conditionsModule.conditions)
• Antiphospholipid Syndrome (APS) (protocolSection.conditionsModule.conditions)
• Rheumatoid Arthritis (RA) (protocolSection.conditionsModule.conditions)
• IgG4-Related Diseases (protocolSection.conditionsModule.conditions)
• Sjogren's Syndrome (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['YTS109 cell'], 'description': 'Subjects will receive YTS109 cell (1.5 E6 STAR +T cells/kg) once in this study.', 'name': 'YTS109 cell', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

• YTS109 cell (protocolSection.armsInterventionsModule.interventions[].name)

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.